ANVS
Annovis Bio, Inc.
NYSE · Healthcare · Biotechnology · US
$0.98
−1.35%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
1164.0%
Return on equity
-224.7%
Return on assets
1164.2%
Return on invested capital
0.00x
Asset turnover
-$43.3M
Cash from operations
$0.44
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026